There is mounting evidence that glucose responsive insulin delivery via hybridclosed-loop (HCL) systems results in improved glycemic control, greater quality oflife and reduced diabetes burden for people with T1D.14, , -17 HCL systems require users tobolus manually for meals. The gene discussed is INS; the disease is diabetes mellitus.